Epirubicin and condition aggravated Patient Reports February 12, 2012

Epirubicin Side Effects Report #4653235-7
Epirubicin side effect was reported by a Physician from on Apr 20, 2005. Male patient, 61 years of age, was diagnosed with lymphoma  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: amnesia, condition aggravated, dementia . Epirubicin dosage: 50 MG (CYLICAL), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISONE, RITUXIMAB. Patient recovered.

Epirubicin Side Effects Report #4680749-6
Epirubicin side effect was reported by a Physician from on May 20, 2005. Male patient, 61 years of age, was diagnosed with lymphoma  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: amnesia, condition aggravated, dementia . Epirubicin dosage: 50 MG, INTRAVENOUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient recovered.

Epirubicin Side Effects Report #4960319-2
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Mar 14, 2006. Female patient, 49 years of age, was diagnosed with ill-defined disorder, breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: chills, condition aggravated, confusional state, infection , leukopenia, nausea , neutropenia, pyrexia, thrombocytopenia. Epirubicin dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, METHOTREXATE, LANSOPRAZOLE, WARFARIN, BECLOMETHASONE DIPROPIONATE, CYCLIZINE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4855966-2
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Dec 02, 2005. Female patient, 79 years of age, weighting 175.7 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomyopathy , condition aggravated, myocardial infarction. Epirubicin dosage: 135 MG (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, TAXOL, LIPITOR, ACTOS, COREG, LASIX, SPIRONOLACTONE. Patient recovered.


Epirubicin Side Effects Report #4868653-1
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2005. Female patient, 79 years of age, weighting 175.7 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomyopathy , condition aggravated, myocardial infarction. Epirubicin dosage: 135 MG (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, TAXOL, LIPITOR, ACTOS, COREG, LASIX, SPIRONOLACTONE. Patient recovered.

Epirubicin Side Effects Report #4582163-0
Epirubicin side effect was reported by a Health Professional from on Nov 24, 2004. Female patient, 56 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, condition aggravated, diabetes mellitus, heart rate increased, respiratory rate increased. Epirubicin dosage: 150 MG, EVERY 21 DAYS, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CYCLOPHOSPHAMIDE, PROCHLORPERAZINE EDISYLATE, ONDANSETRON, DEXAMETHASONE, FUROSEMIDE, GRANISETRON, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4629871-0
Epirubicin side effect was reported by a Physician from on Mar 24, 2005. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with ill-defined disorder and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, cough, cryptogenic organizing pneumonia, myalgia, pulmonary hypertension , pulmonary veno-occlusive disease, viral infection . Epirubicin dosage: 60 MG (CYCLIC INTERVAL: EVERY MONTH), INTRAVENOUS. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4645529-6
Epirubicin side effect was reported by a Physician from on Apr 15, 2005. Male patient, 48 years of age, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, cough, cryptogenic organizing pneumonia, myalgia, pulmonary hypertension , pulmonary veno-occlusive disease, viral infection . Epirubicin dosage: 60 MG (2 CYCLE INTERVAL: DAILY), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CYCLOPHOSPHAMIDE, PREDNISOLONE PHOSPHATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4738455-5
Epirubicin side effect was reported by a Physician from FRANCE on July 21, 2005. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with ill-defined disorder and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, cough, cryptogenic organizing pneumonia, myalgia, pulmonary hypertension , pulmonary veno-occlusive disease. Epirubicin dosage: 60 MG (CYCLIC INTERVAL: EVERY MONTH), INTRAVENOUS. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.